A22D (p.Ala22Asp) variant of MS4A1 (B-lymphocyte antigen CD20)

A22D (p.Ala22Asp) in MS4A1 (B-lymphocyte antigen CD20) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of not provided. The available variant effect predictions contribute to a CATVariant prioritization score of 0.30 / 1. The record also includes structural context.

A22D (p.Ala22Asp) variant details